Pentagon Rebrands Havana Syndrome Response, Funds Compensation, and Validates BrainHQ Treatment
Event summary
- Pentagon renames Havana Syndrome task force to 'Directed Energy Bio-Effects Cross-Functional Team' six months after Donald Trump’s comments on 'discombobulator' weapons.
- Walter Reed study published in Frontiers in Neurology shows BrainHQ exercises significantly reversed cognitive damage in 40 Havana Syndrome patients.
- $3 million in compensation payouts allocated for affected personnel.
- BrainHQ usage led to 75% of patients reporting improvements in memory, visuo-spatial skills, and attention.
The big picture
The Pentagon’s strategic pivot from 'anomalous health incidents' to 'directed energy bio-effects' marks a significant shift in how it views and treats Havana Syndrome. This rebranding, coupled with compensation and validated treatment options, signals a broader industry trend toward recognizing and addressing non-kinetic weapons' health impacts. The study’s findings could position BrainHQ as a critical tool in military and civilian cognitive rehabilitation, expanding its market potential.
What we're watching
- Treatment Validation
- How the Pentagon’s endorsement of BrainHQ will affect its adoption in military and civilian healthcare.
- Policy Shift
- Whether the Pentagon’s rebranding and compensation will accelerate research into directed energy bio-effects.
- Market Opportunity
- The pace at which Posit Science can capitalize on the military’s validation of BrainHQ for broader applications.